A detailed history of Primecap Management CO transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Primecap Management CO holds 2,876,440 shares of WVE stock, worth $18.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,876,440
Previous 3,759,408 23.49%
Holding current value
$18.7 Million
Previous $19 Million 6.52%
% of portfolio
0.01%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$3.54 - $6.84 $3.13 Million - $6.04 Million
-882,968 Reduced 23.49%
2,876,440 $17.7 Million
Q4 2023

Feb 09, 2024

SELL
$4.16 - $6.87 $87,776 - $144,957
-21,100 Reduced 0.56%
3,759,408 $19 Million
Q3 2023

Nov 13, 2023

SELL
$3.56 - $5.75 $110,004 - $177,675
-30,900 Reduced 0.81%
3,780,508 $21.7 Million
Q2 2023

Aug 11, 2023

SELL
$3.51 - $4.69 $1.3 Million - $1.73 Million
-369,700 Reduced 8.84%
3,811,408 $13.9 Million
Q1 2023

May 15, 2023

SELL
$3.58 - $6.3 $30,430 - $53,550
-8,500 Reduced 0.2%
4,181,108 $18.1 Million
Q4 2022

Feb 13, 2023

SELL
$3.18 - $7.0 $700,554 - $1.54 Million
-220,300 Reduced 5.0%
4,189,608 $29.3 Million
Q3 2022

Nov 14, 2022

SELL
$2.37 - $4.28 $40,053 - $72,332
-16,900 Reduced 0.38%
4,409,908 $15.9 Million
Q2 2022

Aug 11, 2022

SELL
$1.23 - $3.25 $165,394 - $437,017
-134,467 Reduced 2.95%
4,426,808 $14.4 Million
Q1 2022

May 11, 2022

SELL
$2.0 - $3.28 $66,600 - $109,224
-33,300 Reduced 0.72%
4,561,275 $9.12 Million
Q4 2021

Feb 11, 2022

BUY
$3.14 - $5.15 $80,384 - $131,840
25,600 Added 0.56%
4,594,575 $14.4 Million
Q3 2021

Nov 12, 2021

SELL
$4.89 - $7.12 $90,909 - $132,367
-18,591 Reduced 0.41%
4,568,975 $22.4 Million
Q2 2021

Aug 10, 2021

SELL
$5.65 - $7.47 $442,869 - $585,528
-78,384 Reduced 1.68%
4,587,566 $30.6 Million
Q1 2021

May 14, 2021

BUY
$5.61 - $12.01 $4.16 Million - $8.91 Million
741,475 Added 18.89%
4,665,950 $26.2 Million
Q4 2020

Feb 08, 2021

BUY
$6.99 - $9.26 $4.36 Million - $5.77 Million
623,080 Added 18.87%
3,924,475 $30.9 Million
Q3 2020

Nov 13, 2020

BUY
$8.49 - $19.54 $16.9 Million - $38.8 Million
1,985,241 Added 150.84%
3,301,395 $28 Million
Q2 2020

Aug 13, 2020

BUY
$7.44 - $11.29 $599,411 - $909,590
80,566 Added 6.52%
1,316,154 $13.7 Million
Q1 2020

May 14, 2020

SELL
$6.94 - $14.22 $403,436 - $826,637
-58,132 Reduced 4.49%
1,235,588 $11.6 Million
Q4 2019

Feb 14, 2020

BUY
$7.99 - $37.6 $3.71 Million - $17.5 Million
464,219 Added 55.96%
1,293,720 $10.4 Million
Q3 2019

Nov 13, 2019

BUY
$19.17 - $27.4 $15.9 Million - $22.7 Million
829,501 New
829,501 $17 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $565M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.